Dezima Pharma Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Dezima Pharma General Information

Description

Developer of novel drugs intended to treat dyslipidemic patients suffering from cardiovascular disease. The company develops a cholesteryl ester transfer protein inhibitor that acts as a pharmacological therapy to lower low-density lipoprotein cholesterol and hence lower cardiovascular disease, thereby enabling clinicians to treat dyslipidemic patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
NewAmsterdam Pharma
Primary Office
  • Gooimeer 2 - 35
  • 1411 DC Naarden
  • Netherlands
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dezima Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dezima Pharma‘s full profile, request access.

Request a free trial

Dezima Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel drugs intended to treat dyslipidemic patients suffering from cardiovascular disease. The company deve
Drug Discovery
Naarden, Netherlands
0000
000000&0

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000 000000000
Cary, NC
000000&0

000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000
Bridgewater, NJ
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dezima Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Altavant Sciences Corporate Backed or Acquired Cary, NC 000000&0
000000 Formerly VC-backed Bridgewater, NJ 000 00000 000000000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
000000000 Corporation Southampton, United Kingdom 00 00000 000000000 00000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Dezima Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dezima Pharma‘s full profile, request access.

Request a free trial